Deerland Enzymes & Probiotics hires Vice President of Marketing & Strategy

Deerland Enzymes, an international enzyme and probiotic-based dietary supplement formulator and contract manufacturer, announces that Sam Michini has joined the company as Vice President of Marketing and Strategy

Michini joins Deerland with more than 25 years of experience in the pharmaceutical, vitamin, mineral and supplement industry.

Most recently, Sam served as the Vice President of Sales, Marketing and New Product Development for Delavau Pharmaceutical Partners in Philadelphia (PA, USA).

Prior to Delavau, he led commercialisation and corporate strategy efforts for Dakota Life Sciences as Executive Vice President and Chief Commercial Officer.

He holds a degree in communication from Niagara University.

Scott Ravech, CEO of Deerland, stated: “I’m excited for Sam to join our team; he’s a proven leader in creating and implementing growth strategies across both dietary supplement and pharmaceutical platforms."

"The diversity of his experience in these areas will undoubtedly help Deerland sustain the significant growth that we’ve experienced during the past decade.”

You may also like

Ingredients

Deerland granted patent for Bacillus subtilis probiotic

The patent summarises studies of 30, 60 and 90 days in individuals with bowel irregularity who consumed <i>B. subtilis</i>, all resulting in measurable improvements
Ingredients

Deerland Probiotics & Enzymes positioned to collaborate with customers worldwide

Customers now have full access to an expanded portfolio of science-backed probiotic, prebiotic and enzyme technologies
Ingredients

Enzyme blend ProHydrolase potentiates amino acid uptake

A newly published study adds to the portfolio of research demonstrating that ProHydolase, a proprietary protease enzyme blend from Deerland Probiotics & Enzymes, enhances the benefit of whey protein when taken together
Ingredients

Deerland acquires Bifodan to boost global footprint

Acquisition gives the US-based company greater European reach with HQ in Denmark
Ingredients

Deerland receives GRAS No Objection Letter from FDA for probiotic DE111

In addition to the FDA letter, DE111 has previously received non-Novel Food status in both Canada and Australia, as well as approval as a natural health product ingredient by Health Canada
Research & Development

Deerland PreforPro effect on gut microbiota gets scientific support

The phage cocktail modifies several bacterial species, including increased populations of the genera <em>Eubacterium</em>, new study finds
Research & Development

Probiotic strain DE111 found to reduce proinflammatory compound in athletes

A new study has found that athletes who consumed a probiotic daily may benefit by boosting immunity and recovery following strenuous training or play by reducing levels of tumor necrosis factor-alpha (TNF-alpha), a proinflammatory compound
Subscribe now